Can You Take Wegovy Forever — or Does Treatment Have a Time Limit?

What trials tell us about stopping semaglutide, and why it matters

The most instructive data on this question comes from the STEP 1 extension study. In the main STEP 1 trial, published in the New England Journal of Medicine, adults using semaglutide 2.4mg alongside lifestyle changes lost an average of around 15% of body weight over 68 weeks. When participants then stopped the medicine, a significant proportion of that weight returned within a year, with or without continued lifestyle support.

That finding is not a criticism of the medicine. It reflects how obesity works biologically: the hormonal and appetite signals that drove weight gain in the first place tend to reassert themselves once the pharmacological support is removed. So asking whether you can stay on Wegovy forever is really asking whether the condition it treats is itself permanent, and for many people, it is. Our Wegovy overview covers the mechanism behind this in more depth.

Nothing in the licensed indication prevents extended use if treatment remains appropriate and well-tolerated. The decision rests on ongoing clinical review rather than a calendar date.

Where the NICE two-year rule comes from, and what it does and does not mean

NICE's recommendation for semaglutide (TA875) was written for NHS commissioning in specialist weight management services. It states that semaglutide should be used for a maximum of two years within that setting. That ceiling is a commissioning boundary, not a pharmacological verdict on safety after 26 months.

The NICE appraisal of Wegovy (TA875) also states that if a patient has not achieved at least 5% weight loss after six months at the maintenance dose, continuing treatment should be reconsidered. That is a clinically sensible threshold applied at every review, not just at two years.

For people accessing Wegovy privately through a regulated pharmacy, the NICE two-year cap does not automatically apply in the way it does within NHS specialist services. Private prescribing is governed by the medicine's licence and by the prescriber's clinical judgement at each review. If you are wondering whether being on Wegovy forever is a realistic possibility for you specifically, that is worth raising directly with your prescribing team. Exploring the weight-loss treatment options available privately gives you a sense of how that decision is structured.

Whether taking Wegovy long term is appropriate for you

Three things shape the answer in practice. First, ongoing effectiveness: if weight loss has plateaued at a level the prescriber considers insufficient, or if regain is occurring despite treatment, the clinical picture changes. Second, tolerability: most gastrointestinal side effects settle in the first weeks of treatment or after each dose increase, but a small number of people experience persistent symptoms that shift the benefit-risk calculation over time. Third, the reason for treatment in the first place, someone managing significant cardiovascular risk alongside obesity has a different long-term case than someone near the lower eligibility threshold.

One practical checking habit: at each repeat order, note your current weight against where you started. A rough percentage figure takes under a minute to calculate and gives your prescribing team an immediate anchor for the clinical conversation. Our prescribers use exactly this kind of data at every review. If you are curious about whether Wegovy has to be a permanent commitment, the short answer is that it does not, but stopping should be planned with your prescriber rather than done suddenly.

The NHS patient information on semaglutide covers what to expect when changing or stopping treatment, and is worth reading alongside your Patient Information Leaflet.

How the cost picture changes over a longer course of treatment

Extended use naturally affects the overall cost of private treatment. Eli Lilly's UK list-price increase in September 2025 pushed Mounjaro prices upward; Wegovy has followed a similar trajectory and private monthly costs vary by dose and provider. If you are using a cartridge-based format, it is also worth familiarising yourself with how to mix a semaglutide cartridge correctly, as preparation errors can affect how much of each dose you actually receive. Our Wegovy price comparison guide for the UK lays out what to look for and what is frequently excluded from headline figures.

At nume, every repeat order includes a fresh clinical review by a GPhC-registered prescriber, a real clinician reads your updated information, not an automated system. There is no subscription and no auto-renewal; each order is an active decision on both sides. The same transparent price covers your prescription, your consultation, and free next-working-day tracked delivery. If you want to understand what that looks like in practice, our about us page explains the pharmacy structure behind the service.

If you are ready to discuss whether continued or ongoing treatment is right for you, the right starting point is a clinical conversation. Check your eligibility with our prescribers, consultations are free and reviewed the same day.